Major vaccine exporters

Major vaccine exporters

Major vaccine exporters

The rate of vaccination depends on the rate of vaccine development and production, and also on a smooth vaccination roll-out. COVAX has invested more than €1 000 million in research and development of new vaccines. This also includes a market place managed by CEPI, that has helped address bottlenecks in the production of the some 200 components required to produce a vaccine.


Related Articles

Be the first to write a comment.

Leave a Reply

EPRS Logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.